The latest example of this trend is Merck KGaA’s impending all-cash acquisition of SpringWorks Therapeutics, valued around ...
Hosted on MSN6h
The New Gold Rush in Rare Disease Treatments and Merck KGaA’s Acquisition of SpringWorks TherapeuticsFor many years, the pharmaceutical business concentrated mostly on blockbuster medications, which are cures for common ...
SpringWorks Therapeutics (NASDAQ:SWTX) jumped 10% in premarket trading after the firm reported its Q4 results and canceled ...
1don MSN
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New ...
Arabian Post on MSN4d
Entrepreneurs Poised To Capitalize On Emerging Trends In 2025As 2025 unfolds, entrepreneurs are strategically positioning themselves to harness emerging trends across various sectors.
Merck’s interest in SpringWorks — and its purchase of ... in August with a $126 million financing round for Halda Therapeutics, a cancer drug company founded by Yale bioscience innovator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback